Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

A novel NOS inhibitor possibly involved in elevating arterial pressure

Feb. 18, 1998

rAAV vector to be evaluated for cardiovascular gene transfer

Feb. 17, 1998

KR-30450 exerts cardioprotective effects in ischemic rat hearts

Feb. 16, 1998

Successful results contribute to early termination of phase IIa study of TBC-11251

Feb. 13, 1998

Icos reveals new cGMP-specific PDE inhibitors

Feb. 12, 1998

Antibradycardic M2 receptor antagonists prepared at Yamanouchi

Feb. 11, 1998

Inex acquires antisense assets from Lynx

Feb. 10, 1998

Captopril demonstrates antioxidant activity in new in vitro assay

Feb. 9, 1998

CV Therapeutics, Cleveland Clinic Foundation collaborate on study of CVT-313

Feb. 6, 1998

Corlopam finally on the market -- U.S. is country of first launch

Feb. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...